Concepedia

Mrinalini Tavag

MT

5

Publications

245

Citations

5

H-Index

2013

Active since

Affiliations

University of Michigan(Current)

Mrinalini Tavag is an author at University of Michigan specializing in medicine, molecular biology, and protein engineering.

Top concepts

Publications per year

2013–2017

5

Publications

5

Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration

Joshua D. Stein, Paula Anne Newman-Casey, Mrinalini Tavag et al. · Ophthalmology · 2014 · 83 citations · Full text

, , +3

Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

David W. Hutton, Paula Anne Newman-Casey, Mrinalini Tavag et al. · Health Affairs · 2014 · 76 citations · Full text

CbtA toxin of Escherichia coli inhibits cell division and cell elongation via direct and independent interactions with FtsZ and MreB

Danielle M. Heller, Mrinalini Tavag, Ann Hochschild · PLoS Genetics · 2017 · 52 citations · Full text

, , +19

UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication

Dawn N. Ward, Daniel C. Talley, Mrinalini Tavag et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 20 citations · Full text

, , +10

Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration (an American Ophthalmological Society thesis).

Joshua D. Stein, Paula Anne Newman-Casey, Mrinalini Tavag et al. · PubMed · 2013 · 14 citations

Rows per page

1–5 of 5